Birkenstock Accelerates Share Repurchase; Valuation Remains Stretched

What happened

Birkenstock announced an accelerated share repurchase program, fueling a sharp rebound after the stock had fallen to all-time lows since its 2023 IPO. The buyback signals management's confidence in the business and provides near-term support for shares. However, the company remains a high-quality franchise with strong margins and double-digit growth, but it trades at ~24x earnings and ~17x EV/EBITDA, well above a conservative DCF estimate of ~$26. Persistent risks include design-copy vulnerability, new U.S. tariffs, unresolved internal control weaknesses, and a leveraged balance sheet with a large tax receivable agreement. The repurchase does not address these structural overhangs, and the valuation still embeds aggressive assumptions for sustained growth.

Implication

In the near term, the accelerated buyback may reduce share count and support price, but it does not improve underlying fundamentals. The company still faces headwinds from tariffs, weak IP protection, and governance issues. Moreover, the stock trades at a large premium to intrinsic value, leaving limited margin of safety. Investors should watch for evidence of tariff pass-through, margin resilience, and control remediation before becoming more constructive. Until then, the risk/reward is unattractive for value-oriented investors, and the buyback alone does not justify a change from a WAIT stance.

Thesis delta

The accelerated share repurchase does not alter the fundamental thesis; the stock remains a quality business at a quality-plus-risk price. The buyback signals management confidence but does not mitigate key risks like tariffs and governance. The stance stays at WAIT, as the current price still offers limited margin of safety relative to conservative intrinsic value.